SCHEMBL6873113

SCHEMBL6873113

C[C@H](NC(=O)Nc1ccccc1)C(N)=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.62
MAPK1 P28482 1/20 0.57
EPHX2 P34913 2/20 0.57
SMN1; SMN2 Q16637 4/20 0.55
TP53 P04637 1/20 0.55
EPHX1 P07099 1/20 0.55
TSHR P16473 1/20 0.55
CDK9 P50750 1/20 0.55
CLK4 Q9HAZ1 1/20 0.55
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
TAAR1 Q96RJ0 2/20 0.50
KMT2A Q03164 1/20 0.50
KDM4E B2RXH2 1/20 0.49
CNR1 P21554 2/20 0.49
CASP3 P42574 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
MAOA P21397 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1903330 1.00 HSD17B10 (0.62) HSD17B10MAPK1EPHX2SMN1; SMN2TP53
SCHEMBL15971313 0.85 HSD17B10 (0.66) HSD17B10MAPK1EPHX2SMN1; SMN2TP53
SCHEMBL6374964 0.85 HSD17B10 (0.66) HSD17B10MAPK1EPHX2SMN1; SMN2TP53
SCHEMBL9056827 0.85 HSD17B10 (0.66) HSD17B10MAPK1EPHX2SMN1; SMN2TP53
SCHEMBL29687180 0.84 KIF11 (0.51) MAPK1TP53TSHRNPC1RAB9A
SCHEMBL20334992 0.84 MAPK1 (0.78) HSD17B10MAPK1EPHX2SMN1; SMN2TP53
SCHEMBL20334993 0.84 MAPK1 (0.78) HSD17B10MAPK1EPHX2SMN1; SMN2TP53
SCHEMBL29687222 0.84 KIF11 (0.51) MAPK1TP53TSHRNPC1RAB9A
SCHEMBL29687159 0.83 MDM2 (0.58) MAPK1SMN1; SMN2TP53TSHRCLK4
SCHEMBL29687046 0.83 KIF11 (0.58) MAPK1EPHX2SMN1; SMN2TP53EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1452522-A2 Novel compounds and compositions as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2004-09-01 EP disclosed